Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ZELTIQ Aesthetics Inc (NASDAQ:ZLTQ)

55.67
Delayed Data
As of Feb 17
 -0.02 / -0.04%
Today’s Change
19.95
Today|||52-Week Range
56.18
+27.92%
Year-to-Date
EULAV Asset Management Buys Pioneer Natural Resources Co, Salesforce. ...
Feb 16 / GuruFocus News - Paid Partner Content
Mid-Afternoon Market Update: Dow Rises 150 Points; Zeltiq Aesthetics Shares Surge Fol...
Feb 13 / Benzinga - Paid Partner Content
Biotech Buoyed by Deal Talk
Feb 15 / TheStreet.com - Paid Partner Content
How to Trade Monday's Most Active Stocks: BofA, Vale, Zeltiq, Teva and More
Feb 13 / TheStreet.com - Paid Partner Content
Valeant, Pershing Square Will Split Legal Costs on Allergan Lawsuit
Feb 14 / TheStreet.com - Paid Partner Content
Why Zeltiq Aesthetics Stock Is Surging Higher Today
Feb 13 / MotleyFool.com - Paid Partner Content
Allergan To Acquire ZELTIQ in $2.47 Billion Deal, ZELTIQ Shares Pop 13%
Feb 13 / Zacks.com - Paid Partner Content
Allergan Shares Rise on $2.5B Deal for Body-Sculptor Zeltiq
Feb 13 / TheStreet.com - Paid Partner Content
Why Chemours, Zeltiq Aesthetics, and Vale Jumped Today
Feb 13 / MotleyFool.com - Paid Partner Content
Up Goes My Allergan Price Target Again
Feb 13 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close55.69
Today’s open55.70
Day’s range55.52 - 55.72
Volume2,471,390
Average volume (3 months)1,142,655
Market cap$2.2B
Dividend yield--
Data as of 3:59pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)+2,450.00%
Earnings growth (this year)-107.16%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+46.39%
P/E ratio74.2
Price/Sales4.56
Price/Book17.56

Competitors

 Today’s
change
Today’s
% change
MSAMSA Safety Inc+0.56+0.81%
WMGIWright Medical Group...+0.15+0.56%
ITGRInteger Holdings Cor...+0.10+0.28%
OFIXOrthofix Internation...+0.04+0.11%
Data as of 4:02pm ET, 02/17/2017

Financials

Next reporting dateMarch 7, 2017
EPS forecast (this quarter)$0.16
Annual revenue (last year)$255.4M
Annual profit (last year)$41.8M
Net profit margin16.37%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Mark J. Foley
Vice President-
Operations
Carl Lamm
Corporate headquarters
Pleasanton, California

Forecasts


Search for Jobs